Catapano Joseph Ronald 4

4 · Teladoc Health, Inc. · Filed Mar 3, 2026

Form 4

Period: 2026-02-27

Chief Accounting Officer

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-02-27+3,333→ 10,019 total
Exercise/Conversion
Common Stock
[F2]
2026-02-27+155→ 10,174 total
Sale
Common Stock
[F3]
2026-03-02$5.12/sh−1,333$6,821→ 8,841 total
Exercise/Conversion
Restricted Stock Units
[F1][F4]
2026-02-27−3,333→ 6,667 total
→ Common Stock (3,333 underlying)
Award
Performance Stock Units
[F5][F6]
2026-02-27+465→ 465 total
→ Common Stock (465 underlying)
Exercise/Conversion
Performance Stock Units
[F2][F7]
2026-02-27−155→ 310 total
→ Common Stock (155 underlying)
Award
Restricted Stock Units
[F8][F9]
2026-03-01+15,000→ 15,000 total
→ Common Stock (15,000 underlying)

Footnotes (9)

[F1]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
[F2]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
[F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
[F4]On March 1, 2025, the reporting person was granted 10,000 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
[F5]Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
[F6]Performance award amount determined based on metrics in respect of the issuer's 2025 financial results.
[F7]On March 1, 2026, the reporting person earned 465 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
[F8]Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
[F9]One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Signature

/s/ Adam C. Vandervoort, Attorney-in-Fact|2026-03-03

Documents

1 file